These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19147685)

  • 1. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
    Bian Y; Masuda A; Matsuura T; Ito M; Okushin K; Engel AG; Ohno K
    Hum Mol Genet; 2009 Apr; 18(7):1229-37. PubMed ID: 19147685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
    Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
    Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA.
    Rahman MA; Masuda A; Ohe K; Ito M; Hutchinson DO; Mayeda A; Engel AG; Ohno K
    Sci Rep; 2013 Oct; 3():2931. PubMed ID: 24121633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.
    Ohno K; Rahman MA; Nazim M; Nasrin F; Lin Y; Takeda JI; Masuda A
    J Neurochem; 2017 Aug; 142 Suppl 2():64-72. PubMed ID: 28072465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome.
    Rahman MA; Azuma Y; Nasrin F; Takeda J; Nazim M; Bin Ahsan K; Masuda A; Engel AG; Ohno K
    Sci Rep; 2015 Aug; 5():13208. PubMed ID: 26282582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
    Tei S; Ishii HT; Mitsuhashi H; Ishiura S
    Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
    Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
    J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein.
    Markovtsov V; Nikolic JM; Goldman JA; Turck CW; Chou MY; Black DL
    Mol Cell Biol; 2000 Oct; 20(20):7463-79. PubMed ID: 11003644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream.
    Chan RC; Black DL
    Mol Cell Biol; 1997 Aug; 17(8):4667-76. PubMed ID: 9234723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polypyrimidine tract binding protein regulates desaturase alternative splicing and PUFA composition.
    Reardon HT; Park WJ; Zhang J; Lawrence P; Kothapalli KSD; Brenna JT
    J Lipid Res; 2011 Dec; 52(12):2279-2286. PubMed ID: 21980057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
    Carstens RP; Wagner EJ; Garcia-Blanco MA
    Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of alpha-actinin SM exon splicing by assisted binding of PTB to the polypyrimidine tract.
    Matlin AJ; Southby J; Gooding C; Smith CW
    RNA; 2007 Aug; 13(8):1214-23. PubMed ID: 17592047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping.
    Xue Y; Zhou Y; Wu T; Zhu T; Ji X; Kwon YS; Zhang C; Yeo G; Black DL; Sun H; Fu XD; Zhang Y
    Mol Cell; 2009 Dec; 36(6):996-1006. PubMed ID: 20064465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exons.
    Southby J; Gooding C; Smith CW
    Mol Cell Biol; 1999 Apr; 19(4):2699-711. PubMed ID: 10082536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries.
    Ohno K; Tsujino A; Shen XM; Milone M; Engel AG
    J Med Genet; 2005 Aug; 42(8):e53. PubMed ID: 16061559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
    J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of PTB bound to RNA: specific binding and implications for splicing regulation.
    Oberstrass FC; Auweter SD; Erat M; Hargous Y; Henning A; Wenter P; Reymond L; Amir-Ahmady B; Pitsch S; Black DL; Allain FH
    Science; 2005 Sep; 309(5743):2054-7. PubMed ID: 16179478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome.
    Müller JS; Stucka R; Neudecker S; Zierz S; Schmidt C; Huebner A; Lochmüller H; Abicht A
    Neurology; 2005 Aug; 65(3):463-5. PubMed ID: 16087917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.